NeoTight™ Eye Serum

Brighter-looking eyes, with visible results that deepen over time.

Expert grading documented significant Week 6 improvements across dark circles, puffiness, and peri-orbital lines - a focused visible-results story for the delicate eye area.

33 completed6 weeksExpert gradedVCS sample SA211001SGF20117-01

38.10%

mean improvement in dark-circle appearance

Week 6

Expert grading, n=33; p<0.001.

23.12%

mean improvement in puffiness and bags

Week 6

Expert grading, n=33; p<0.001.

100%

said the delicate eye area felt nourished

Week 6

Participant perception, n=33.

Results that build

Visible improvement progressed through Week 6.

Dark circles / discoloration38.10%

Expert-graded mean improvement; n=33; p<0.001.

Puffiness / bags23.12%

Expert-graded mean improvement; n=33; p<0.001.

Peri-orbital fine lines8.82%

Expert-graded mean improvement; n=31; p<0.001.

Immediate performance

Fifteen minutes after the first application, Cutometer readings showed an 8.31% improvement in R0 firmness (n=27; p=0.039) and a 15.16% improvement in R5 elasticity (n=27; p=0.001). These immediate instrument findings are presented separately from the Week 4 and Week 6 expert-graded appearance results.

Selected Week 6 participant perceptions

93.94%reported increased smoothness.

93.94%agreed the lightweight texture absorbed quickly, leaving skin soothed and refreshed.

84.85%saw brighter-looking dark circles.

84.85%saw improved bags and puffiness.

75.76%saw improved-looking fine lines.

78.79%saw improved eyelid crepiness.

Technical study record

A signed final source supports the visible eye-area story.

Independent laboratoryValidated Claim Support, LLC

Study / reportCS201061 / RE201061.V01

Tested articleNeoTight Revitalizing Eye Serum SA211001 / SGF20117-01

Design6-week single-arm study with 7-day washout

Population37 enrolled; 33 completed; ages 36-69

UseTwice daily around the eye area

EvidenceExpert grading, Cutometer, photography, questionnaire

Source date8 April 2021

Expert-graded mean change from baseline

Expert endpoint	15 minutes	Week 4	Week 6
Dark circles / discoloration	-10.20%; n=33; p<0.001	-31.95%; n=32; p<0.001	-38.10%; n=33; p<0.001
Puffiness / bags	-8.67%; n=33; p<0.001	-16.55%; n=32; p<0.001	-23.12%; n=33; p<0.001
Peri-orbital fine lines	-1.18%; n=31; p=0.161	-4.57%; n=30; p=0.001	-8.82%; n=31; p<0.001

Lower grades indicate improvement. n is shown for every endpoint and timepoint.

Instrumental timing context

Cutometer parameter	15 minutes	Week 4	Week 6
R0 firmness	-8.31%; p=0.039	+32.00%; p<0.001	+35.17%; p<0.001
R5 elasticity	+15.16%; p=0.001	-15.74%; p<0.001	-12.04%; p=0.005

R0 decrease and R5 increase indicate improvement. The favorable Cutometer response was recorded at 15 minutes; Week 4 and Week 6 values are included for complete timing context.

Study context

Thirty-three participants completed the study. Two mild adverse events were recorded and no participant withdrew. Results apply to NeoTight Revitalizing Eye Serum SA211001 / SGF20117-01 under the reported six-week design.

Independent laboratory evidence

Original source pages follow.

View the complete source record.

Selected original VCS pages follow, preserving the study summary, methods, complete aggregate questionnaires, conclusion, authorization, and Quality Assurance evidence. Expert-grade and Cutometer results are reproduced in aggregate on the preceding technical page; participant-level listings are excluded.

The complete PDF pairs this consumer summary with the selected independent laboratory source pages.

Open full PDF + laboratory source

LaboratoryValidated Claim Support, LLC

Study / reportCS201061 / RE201061.V01

Source date8 April 2021

AuthenticationDated electronic authorizations + QA/QC

Source authentication

The source contains dated authorization from Principal Investigator Anna Hardy, review by Medical Investigator David A. Wrone, M.D., and independent QA/QC certification dated 9 April 2021.

Source note

Participant identifiers and participant-level measurement rows were removed from the appended result pages; aggregate mean, p-value, and t-value results are unchanged. Week 4 expert endpoint n=30 is used in the summary.

Independent laboratory source pages are included in the complete PDF. Participant-identifying information has been removed where indicated; aggregate findings are unchanged.